Stryker announces acquisition of Inari Medical for $4.9 billion
Deal News | Jan 06, 2025 | Globenewswire
Stryker, a global leader in medical technologies, announced a definitive agreement to acquire Inari Medical for $4.9 billion. This acquisition, priced at $80 per share in cash, will expand Stryker's presence in the peripheral vascular segment, particularly in treating venous thromboembolism (VTE) without thrombolytic drugs. Inari, founded in 2011, has developed innovative solutions for medical conditions such as deep vein thrombosis and pulmonary embolism. Both companies' boards have approved the transaction, with the deal expected to close by the end of Q1 2025, pending regulatory approval and other conditions.
Sectors
- Medical Technology
- Healthcare
Geography
- United States – Both companies, Stryker and Inari Medical, are based in the US; Stryker in Michigan and Inari Medical in California. The acquisition impacts the US healthcare market significantly.
Industry
- Medical Technology – The article involves Stryker, a leading firm in medical technologies, acquiring Inari Medical to broaden its product offerings.
- Healthcare – The acquisition focuses on advancing patient outcomes in the healthcare sector, particularly in the treatment of venous thromboembolism.
Financials
- $4.9 billion – The total acquisition cost for Inari Medical by Stryker.
- $80 per share – The cash offer per share made by Stryker to Inari's shareholders.
- Unspecified impacts to 2025 financial results – Financial impacts to be detailed by Stryker in upcoming earnings call.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Stryker | Acquiring Company | Company | Stryker is a global leader in medical technologies offering innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine. |
| Inari Medical, Inc. | Target Company | Company | Inari is known for its innovative medical solutions, particularly in the peripheral vascular space addressing venous thromboembolism. |
| Kevin Lobo | Chair and CEO | Person | Leadership at Stryker overseeing the acquisition. |
| Drew Hykes | CEO | Person | Leadership at Inari Medical expressing enthusiasm for joining Stryker. |
| U.S. Securities and Exchange Commission (SEC) | Regulatory Body | Government | The SEC is involved via filing requirements for the transaction. |